Tag: Clinical Research Award

Vibhu Sahani | Pharmacology | Lifetime Achievement Award

Published on by World Science Awards

Lifetime Achievement Award

Vibhu Sahani
LLRM Medical College, Meerut
Vibhu Sahani
Affiliation LLRM Medical College, Meerut
Country India
Scopus ID 59031594100
Documents 7
Citations 8
h-index 1
Subject Area Pharmacology
Event World Science Awards

The Lifetime Achievement Award recognizes sustained academic service, scholarly engagement, and professional contributions within a scientific discipline. Vibhu Sahani of LLRM Medical College, Meerut has contributed to the field of pharmacology through research, scholarly publication, and academic activities. The available bibliometric information indicates participation in peer-reviewed scientific communication and ongoing involvement in pharmacological research.[1]

Abstract

Vibhu Sahani is an academic associated with LLRM Medical College, Meerut, India, whose scholarly work is focused on pharmacology. His published research contributes to the understanding of pharmacological science and supports continued advancement in medical research. Available bibliometric indicators, including indexed publications and citations, reflect participation in the international scientific literature and ongoing academic engagement.[1][2]

Keywords

  • Pharmacology
  • Drug Research
  • Medical Science
  • Clinical Pharmacology
  • Biomedical Research
  • Scientific Publications
  • Research Impact
  • World Science Awards

Introduction

Pharmacology is a multidisciplinary scientific field dedicated to understanding the mechanisms, therapeutic applications, efficacy, and safety of medicinal compounds. Research in pharmacology contributes significantly to disease prevention, treatment innovation, and evidence-based healthcare. Academic researchers working in this discipline support advances through laboratory investigations, clinical studies, and scientific publication.[3]

Research Profile

Based on the available Scopus data, Vibhu Sahani has authored seven indexed documents, received eight citations, and holds an h-index of one. These bibliometric indicators demonstrate participation in scholarly research and publication within pharmacology while contributing to the scientific literature through peer-reviewed academic work.[1]

  • Affiliation with LLRM Medical College, Meerut.
  • Primary research area: Pharmacology.
  • Indexed scientific publications: 7.
  • Total citations: 8.
  • Scopus h-index: 1.

Research Contributions

The available publication record indicates contributions to pharmacological investigations and medical science. Research activities in this field support the understanding of therapeutic interventions, drug action, patient care, and evidence-based medicine. Such scholarly contributions form an important part of continued scientific development in healthcare disciplines.[2][3]

Publications

The researcher’s publication portfolio includes peer-reviewed scientific articles indexed within international scholarly databases. These publications demonstrate participation in academic research and dissemination of scientific findings relevant to pharmacology and associated biomedical disciplines.[1]

  • Peer-reviewed journal publications.
  • Pharmacological and biomedical research.
  • Scientific collaboration and academic dissemination.
  • Indexed scholarly contributions.

Research Impact

Research impact is commonly evaluated through publication output, citation performance, scholarly visibility, and contribution to scientific knowledge. The available metrics indicate that Vibhu Sahani has established an indexed research presence in pharmacology. These bibliometric indicators provide objective evidence of participation in scholarly communication while supporting continued academic development.[1]

Award Suitability

Based on the information provided, Vibhu Sahani demonstrates academic engagement through research publication, institutional affiliation, and contributions to pharmacology. Consideration for recognition within the World Science Awards may acknowledge sustained scholarly participation and professional service. Final award decisions should be based on the complete evaluation criteria established by the organizing committee, including academic achievements, research quality, professional experience, and broader scientific contributions.[1][2]

Conclusion

Vibhu Sahani has contributed to pharmacological research through scholarly publication and academic engagement at LLRM Medical College, Meerut. His indexed research record reflects participation in scientific communication and supports ongoing advancement within the biomedical sciences. The documented academic profile provides an objective overview of research activity relevant to professional recognition in the scientific community.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Vibhu Sahani, Author ID 59031594100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59031594100
  2. World Science Awards. (n.d.). Recognition of scientific excellence through international academic awards.
    https://worldscienceawards.com/
  3. Goodman & Gilman’s. The Pharmacological Basis of Therapeutics.
  4. Nature Reviews Drug Discovery. Drug discovery and pharmacological innovation.
    DOI: https://doi.org/10.1038/nrd.2017.232

Ved Pal | Pharmacology | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Ved Pal
Affiliation ISF College of Pharmacy, Moga, Punjab
Country India
Scopus ID 59895257200
Documents 3
Citations 5
h-index 1
Subject Area Pharmacology
Event World Science Awards
ORCID 0000-0003-3523-1469

Ved Pal
ISF College of Pharmacy, Moga, Punjab, India

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate sustained commitment to scientific advancement, innovation, and academic excellence. VED PAL, affiliated with ISF College of Pharmacy, Moga, Punjab, has established an academic profile in the field of pharmacology through research contributions, professional engagement, and participation in internationally recognized scholarly platforms.[1]

Abstract

VED PAL is an academic researcher associated with ISF College of Pharmacy, Moga, Punjab, India. His scholarly interests are centered on pharmacology, an interdisciplinary field that integrates pharmaceutical sciences, biomedical research, and therapeutic innovation. His academic profile reflects ongoing engagement with scientific publication, research dissemination, and professional development within the pharmaceutical sciences.[1][2]

Keywords

Pharmacology, Pharmaceutical Sciences, Drug Research, Biomedical Science, Therapeutics, Academic Research, Scientific Publications, Innovation, World Science Awards, Healthcare Research.

Introduction

Pharmacology remains one of the most significant scientific disciplines supporting healthcare innovation through the study of medicines, therapeutic mechanisms, and biological responses. Researchers working in this field contribute toward improving evidence-based healthcare, advancing pharmaceutical technologies, and supporting interdisciplinary scientific collaboration. Academic recognition programs acknowledge these contributions by evaluating research quality, scholarly productivity, and scientific impact using internationally recognized academic indicators.[2][3]

Research Profile

VED PAL is affiliated with ISF College of Pharmacy in Punjab, India, where his academic interests align with pharmacological research and pharmaceutical sciences. His scholarly identity is represented through internationally recognized researcher identifiers, including a Scopus Author ID and an ORCID profile, supporting transparency in research attribution and academic visibility.[1][4]

Research Contributions

Research activities in pharmacology typically involve investigations related to drug discovery, therapeutic evaluation, pharmacodynamics, pharmacokinetics, toxicology, and clinical relevance. Through academic participation and publication activities, VED PAL contributes to the broader scientific dialogue supporting pharmaceutical research and evidence-driven healthcare. Such contributions encourage collaboration between academic institutions and the scientific community while promoting responsible research practices.[2][5]

Publications

The researcher’s scholarly output is indexed through the Scopus author profile associated with Author ID 59895257200. Publication records, citation data, and bibliographic information are maintained through recognized academic indexing systems, allowing researchers and institutions to monitor scientific productivity and collaboration.[1]

Research Impact

Research impact extends beyond publication volume and includes scientific influence, collaboration, knowledge dissemination, and practical application of research findings. International researcher identifiers such as ORCID and Scopus improve research discoverability, strengthen scholarly communication, and facilitate accurate attribution across academic databases. These systems support transparent evaluation of academic achievements within the global research ecosystem.[1][4]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating commitment to scholarly excellence, ethical research practices, scientific innovation, and meaningful contributions within their discipline. Based on the available academic identifiers, institutional affiliation, and specialization in pharmacology, VED PAL represents a researcher whose profile aligns with the objectives of recognizing ongoing scientific engagement and academic development through the World Science Awards.[5]

Conclusion

VED PAL’s academic profile reflects continued participation in pharmaceutical research and international scholarly communication. Through institutional affiliation, recognized researcher identifiers, and engagement with pharmacological sciences, the profile illustrates a commitment to research integrity, scientific advancement, and professional development. Recognition through the Innovative Research Award highlights the importance of sustained contributions to contemporary scientific research while encouraging future innovation within the pharmaceutical sciences.[1][5]

References

  1. Elsevier. (n.d.). Scopus Author Details: VED PAL, Author ID 59895257200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59895257200
  2. Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2023). Goodman & Gilman’s The Pharmacological Basis of Therapeutics.
    DOI: https://doi.org/10.1038/s41573-021-00234-4
  3. World Health Organization. (n.d.). Research for Health.
    https://www.who.int
  4. ORCID. (n.d.). ORCID Record: 0000-0003-3523-1469.
    https://orcid.org/0000-0003-3523-1469
  5. World Science Awards. (n.d.). Award Evaluation and Recognition Framework.
    https://worldscienceawards.com/

Rushani Cameron | Medicine and Dentistry | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Rushani Cameron
Affiliation SUNY Downstate Health Sciences University, Brooklyn, New York, USA
Country United States
Scopus ID 60539313500
Documents 2
Subject Area Orthopedic Surgery, Sports Medicine, Outcomes Research, Medicine and Dentistry
Event World Science Awards
ORCID 0009-0003-0166-1505

Rushani Cameron
SUNY Downstate Health Sciences University, Brooklyn, New York, USA

Rushani Cameron is a physician-scientist in training whose academic work centers on orthopedic surgery, sports medicine, cartilage restoration, hip preservation, arthroscopy, and clinical outcomes research. As a Doctor of Medicine candidate at SUNY Downstate Health Sciences University, Cameron has developed an active research portfolio through collaborations with NYU Langone Health and Maimonides Medical Center. Her work integrates evidence-based clinical investigation with patient-centered outcome assessment and has resulted in multiple peer-reviewed publications and national scientific presentations.[1]

Abstract

Rushani Cameron has established an emerging academic profile through clinical research in orthopedic surgery and sports medicine. Her investigations evaluate long-term surgical outcomes, graft survivorship, mental health influences on orthopedic recovery, cartilage restoration, and hip preservation. Through collaborations with leading orthopedic researchers, she has contributed to peer-reviewed literature and numerous presentations at internationally recognized conferences, demonstrating a strong commitment to evidence-based clinical research.[2]

Keywords

Orthopedic Surgery, Sports Medicine, Hip Arthroscopy, Cartilage Restoration, Meniscal Allograft Transplantation, Outcomes Research, Orthopedic Research, Medical Education, Clinical Research, Evidence-Based Medicine.

Introduction

Orthopedic surgery increasingly depends upon high-quality clinical evidence to improve patient outcomes and optimize surgical decision-making. Cameron’s academic activities focus on generating clinically relevant evidence addressing sports medicine, hip preservation, cartilage repair, and patient-reported outcomes. Her work reflects interdisciplinary collaboration across academic medical centers and demonstrates an early commitment to translational orthopedic research.[3]

Research Profile

  • Doctor of Medicine Candidate at SUNY Downstate Health Sciences University.
  • Former Orthopedic Research Fellow at NYU Langone Health.
  • Orthopedic Research Scholar at Maimonides Medical Center.
  • Research interests include sports medicine, hip preservation, arthroscopy, cartilage restoration, and clinical outcomes.
  • Recipient of multiple academic honors, including Best Researcher Award, Best Paper Award, and Innovative Research Award.

Research Contributions

Cameron’s research emphasizes long-term evaluation of orthopedic procedures using retrospective cohort studies, registry analyses, and patient-reported outcomes. Her published investigations have examined corticosteroid injections before meniscal transplantation, chondrocyte implantation outcomes, ankle fracture readmissions, posterior tibial slope, and survivorship following meniscal allograft transplantation. Additional ongoing work explores hip arthroscopy, surgical technology, mental health, and cartilage restoration.[4]

Publications

  • Preoperative Intra-Articular Corticosteroid Injection Is Not Associated with Inferior Reoperation or Patient-Reported Outcomes Following Meniscal Allograft Transplantation. DOI: 10.3390/surgeries7020075
  • Patient Comorbidities Drive 90-Day Emergency Department Revisits and Readmissions After Trimalleolar Ankle Fracture ORIF. DOI: 10.5435/JAAOS-D-25-01063
  • Preoperative Corticosteroid Injection and Outcomes Following Chondrocyte Implantation. DOI: 10.3390/surgeries7010040
  • Posterior Tibial Slope and Meniscal Allograft Survivorship. DOI: 10.1002/ksa.70460

Research Impact

The research portfolio demonstrates active participation in clinically meaningful orthopedic investigations addressing patient safety, surgical outcomes, graft survivorship, and long-term functional recovery. Cameron has presented research at major professional organizations including AAOS, AOSSM, ISHA, COS, EOA, OSET, and NMA, illustrating broad dissemination of research findings within the orthopedic community.[5]

Award Suitability

Based on her documented academic record, peer-reviewed publications, leadership activities, and extensive participation in national orthopedic conferences, Rushani Cameron demonstrates characteristics commonly associated with emerging investigator recognition. Her multidisciplinary research, commitment to medical education, and contributions to orthopedic outcomes research support consideration for early-career research recognition within academic medicine.[6]

Conclusion

Rushani Cameron represents an emerging clinician-investigator whose scholarly work spans orthopedic surgery, sports medicine, and outcomes research. Her publication record, conference presentations, leadership roles, and continued engagement in translational orthopedic investigations demonstrate a sustained commitment to advancing evidence-based patient care and medical research.

External Links

References

  1. Elsevier. Scopus Author Details: Rushani Cameron, Author ID 60539313500.
    https://www.scopus.com/authid/detail.uri?authorId=60539313500
  2. Cameron RK et al. Surgeries. 2026.
    https://doi.org/10.3390/surgeries7020075
  3. SUNY Downstate Health Sciences University Curriculum Vitae.
  4. NYU Langone Health Orthopedic Research Portfolio.
  5. American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, Clinical Orthopaedic Society, International Society for Hip Arthroscopy Conference Abstracts.
  6. Curriculum Vitae and documented academic achievements supplied by the researcher.

Muhammad Noman | Health Professions | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Muhammad Noman
The University of Faisalabad, Faisalabad, Pakistan
Muhammad Noman
Affiliation The University of Faisalabad
Country Pakistan
Scopus ID 59599793100
Documents 2
Citations 5
h-index 1
Subject Area Microbiology, Hematology, Health Professions
Event World Science Awards

Muhammad Noman is a Pakistani academic and medical laboratory technologist specializing in molecular diagnostics, hematology, microbiology, histopathology, bio-chemistry, clinical pathology, infectious disease surveillance, and laboratory quality management systems. He currently serves as Senior Lecturer in Medical Laboratory Sciences at The University of Faisalabad and has accumulated extensive experience in laboratory diagnostics, biosafety management, and pandemic-related healthcare operations.[1] His professional contributions include academic teaching, molecular diagnostic testing, operation of Biosafety Level-II and Biosafety Level-III laboratories, and participation in public health initiatives related to COVID-19 and infectious disease control.[2]

Abstract

Muhammad Noman has established a multidisciplinary professional profile in medical laboratory sciences through his involvement in molecular diagnostics, infectious disease surveillance, hematology, microbiology, and laboratory biosafety systems. His work spans academic instruction, laboratory management, diagnostic operations, and healthcare research with emphasis on COVID-19, hepatitis C virus prevalence, dengue fever, and thalassemia-related investigations.[3] He has participated in laboratory quality management training programs, biosafety initiatives, and international academic collaborations while contributing to research publications focused on epidemiology and diagnostic methodologies.[4]

Keywords

Medical Laboratory Sciences, Molecular Diagnostics, Hematology, Histopathology, Microbiology, Clinical Pathology, Biosecurity, Biosafety, Infectious Diseases, COVID-19, Laboratory Quality Management, Disease Surveillance, Molecular Epidemiology, Public Health, Healthcare Research.

Introduction

The advancement of medical laboratory sciences has become increasingly important in the detection, monitoring, and prevention of infectious and non-communicable diseases. Professionals working in diagnostic laboratories contribute significantly to healthcare systems by ensuring accurate laboratory analyses, biosafety compliance, and disease surveillance activities.[5] Muhammad Noman has developed professional expertise across several branches of pathology and laboratory sciences, including microbiology, hematology, immunology, molecular biology, and laboratory biosafety systems.

His professional activities include work in Biosafety Level-II and Level-III laboratory environments, COVID-19 PCR testing, blood banking, laboratory quality assurance, and academic teaching. In addition to laboratory diagnostics, he has participated in workshops and professional development activities related to infectious disease management, laboratory risk management, and clinical pathology systems.[5]

Research Profile

Muhammad Noman completed his Master of Science in Medical Laboratory Sciences from Riphah International University Lahore between 2021 and 2023. Prior to this, he obtained a Bachelor of Science (Honours) degree in Medical Laboratory Technology from Government College University Faisalabad. He also completed specialized technical education in operation theater technology and clinical biochemistry.[1]

His professional experience includes appointments as Lecturer in Medical Laboratory Sciences at The University of Faisalabad, Blood Bank Technologist at Mujahid Hospital Faisalabad, Medical Laboratory Technologist at Allied Hospital Faisalabad, and laboratory staff member at Al-Khidmat Diagnostic Center. His work has involved laboratory diagnostics, infectious disease testing, laboratory supervision, and operation of clinical laboratory systems during pandemic response activities.[2]

Research Contributions

Muhammad Noman’s research activities focus on laboratory diagnostics, epidemiology, and public health-related investigations. His scholarly contributions include studies on hepatitis C virus prevalence, COVID-19 diagnostic methodologies, dengue fever hematological profiling, and mortality-associated factors in thalassemia patients.[3]

He has also contributed to literature associated with CRISPR/Cas technologies and molecular diagnostic approaches in modern biomedical sciences. His involvement in laboratory biosafety and quality management programs demonstrates integration between academic research and clinical laboratory operations.[2]

Publications

  1. Arif, A., Noor-ul-Ain, Munir, A., Noman, M., Munawar, N., Abdelsalam, K., Qari, S. H., & Ahmad, A. (2023). Global Patent Landscape in CRISPR/Cas. In CRISPRized Horticulture Crops, Elsevier.
  2. Noman et al. (2023). Demographic Insights into Hepatitis-C Virus Prevalence among Internally Displaced Persons (IDPs) and Native Populations of Punjab, Pakistan. The Research of Medical Review.
  3. Noman et al. (2025). Role of Immunochromatographic Techniques in the Diagnosis of COVID-19. Indus Journal of Bioscience Research.
  4. Noman et al. (2025). Differential Diagnosis of Different Etiological Markers of COVID-19 among Lab Personals. The Research of Medical Science Review.
  5. Noman et al. (2025). Clinical and Hematological Profiling of Dengue Fever: Impact of Age, Gender, and Comorbidities on Disease Severity. Indus Journal of Bioscience Research.
  6. Noman et al. (2025). Investigate the Mortality, Morbidity and Factors Associated in Thalassemia Patients in Faisalabad, Pakistan. Indus Journal of Bioscience Research.

Research Impact

The research and laboratory activities undertaken by Muhammad Noman contribute to healthcare diagnostics, biosafety awareness, and disease surveillance initiatives within Pakistan’s healthcare and academic sectors. His involvement in molecular diagnostics and infectious disease testing has supported laboratory preparedness during COVID-19 response activities.[3]

Through academic instruction and laboratory supervision, he has participated in the training and development of medical laboratory technology students while maintaining involvement in quality assurance and biosafety systems. His work reflects integration between laboratory sciences, public health surveillance, and healthcare education.[1]

Award Suitability

Muhammad Noman demonstrates qualifications relevant to recognition in the field of medical laboratory sciences and healthcare diagnostics due to his combined contributions to laboratory management, molecular diagnostics, biosafety operations, and academic instruction. His professional engagement with BSL-II and BSL-III laboratory systems, participation in COVID-19 testing operations, and research publications in infectious disease diagnostics indicate substantial involvement in healthcare laboratory sciences.[5]

His participation in national and international workshops, laboratory quality management training, and professional memberships further reflects ongoing engagement with biomedical and laboratory science advancements. These contributions align with the objectives of academic and healthcare research recognition programs.[4]

Conclusion

Muhammad Noman’s academic and professional profile reflects interdisciplinary involvement in medical laboratory sciences, molecular diagnostics, infectious disease surveillance, and laboratory biosafety systems. His combination of clinical laboratory experience, research participation, and academic teaching contributes to the advancement of diagnostic healthcare practices and laboratory sciences education in Pakistan.[2] His continued contributions to research, laboratory management, and healthcare diagnostics support his recognition within biomedical and medical laboratory science communities.

References

  1. Professional academic curriculum vitae and educational background of Muhammad Noman, including qualifications in Medical Laboratory Sciences and Medical Laboratory Technology.
  2. Professional experience records including appointments at The University of Faisalabad, Allied Hospital Faisalabad, Mujahid Hospital, and Al-Khidmat Diagnostic Center.
  3. Research publications associated with infectious disease diagnostics, COVID-19 investigations, dengue fever profiling, and thalassemia-related studies.
  4. Professional certifications and memberships related to biosafety, laboratory quality management systems, and molecular diagnostics training.
  5. World Health Organization. (n.d.). Laboratory biosafety guidance related to infectious diseases and diagnostic systems.

Antra Chaudhary | Pharmaceutical Science | Young Scientist Award

Published on by World Science Awards

Young Scientist Award

Antra Chaudhary,
Jamia Hamdard University, New Delhi, India.

Antra Chaudhary
Affiliation Jamia Hamdard University
Country India
Scopus ID 57406830100
Documents 10
Citations 119
h-index 5
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event World Science Awards
ORCID 0009-0006-9003-5566

Antra Chaudhary is an Indian pharmacology researcher and doctoral scholar recognized for her contributions to bone pharmacology, oxidative stress, inflammatory disorders, and neuroprotection research. Her academic work has focused extensively on translational pharmacological approaches involving medicinal plants, osteoporosis therapeutics, neuroinflammation, stem cell-based therapies, and molecular signaling pathways associated with disease progression and tissue protection.[1] She is currently pursuing doctoral research at Jamia Hamdard University under the supervision of Prof. Divya Vohora, where her investigations explore the therapeutic potential of natural compounds against glucocorticoid-induced bone damage and postmenopausal osteoporosis.[2]

Abstract

This academic article presents a scholarly overview of the research contributions, scientific achievements, and professional development of Antra Chaudhary, a pharmacology researcher specializing in bone pharmacology, oxidative stress, inflammatory disorders, and neuroprotection. Her research has contributed to understanding molecular signaling pathways associated with osteoporosis, ischemic stroke, rheumatoid arthritis, and mitochondrial dysfunction. Through interdisciplinary pharmacological investigations involving in vitro and in vivo models, her work has emphasized translational therapeutic strategies and the use of bioactive compounds for disease modulation.[3] The article further documents her academic qualifications, awards, technical expertise, scientific publications, and suitability for academic recognition in the field of pharmacology and biomedical sciences.

Keywords

Bone Pharmacology, Oxidative Stress, Osteoporosis, Pharmacology, Neuroprotection, Medicinal Plants, Inflammatory Diseases, Stem Cell Therapy, Molecular Pharmacology, Translational Research, Rheumatoid Arthritis, Glucocorticoid-Induced Bone Damage, Pharmacodynamics, Biomedical Sciences.

Introduction

Contemporary pharmacological research increasingly emphasizes translational approaches that integrate molecular biology, therapeutic intervention, and clinical applicability. Researchers in pharmacology are actively investigating novel compounds and signaling pathways to address chronic diseases, neurodegeneration, inflammatory disorders, and metabolic dysfunctions.[4] Within this scientific landscape, Antra Chaudhary has contributed to emerging research areas involving osteoporosis therapeutics, oxidative stress modulation, neuroinflammation, and medicinal plant-based pharmacological interventions.

Her academic journey reflects a progression through pharmaceutical sciences and toxicology training, supported by competitive national examinations including GPAT and NIPER-JEE. She has participated in multidisciplinary research projects and advanced laboratory investigations utilizing molecular, histological, and imaging-based techniques for experimental pharmacology studies.[5]

Research Profile

Antra Chaudhary completed her Master of Science in Pharmacology and Toxicology from the National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, where she worked on medicinal plant extracts from North-East India for inflammatory disease research. Her doctoral research at Jamia Hamdard University focuses on bone pharmacology and oxidative stress biology under the supervision of Prof. Divya Vohora.[2]

Her technical expertise encompasses a broad range of experimental methodologies, including Western blotting, RT-PCR, immunohistochemistry, fluorescence microscopy, micro-computed tomography, small animal imaging, and cell culture systems. She has also demonstrated competence in pharmacological data analysis using GraphPad Prism and image analysis software.[3]

  • DST WISE KIRAN Fellow for doctoral research in Life Sciences.
  • Qualified GPAT and NIPER-JEE examinations with competitive national rankings.
  • Recipient of the Young Investigator Award 2025 at IPC-IPSCON 2025.
  • Contributor to peer-reviewed journals in pharmacology and neuroscience.

Research Contributions

The scientific contributions of Antra Chaudhary span multiple pharmacological domains, including neuroprotection, osteoporosis, inflammatory signaling, and mitochondrial biology. Her collaborative studies have investigated the role of cardiolipin-mediated mitochondrial protection in ischemic stroke and the therapeutic implications of stem cell-mediated inflammasome modulation.[1]

Her work on bone-targeted daidzein-loaded hydroxyapatite nanoparticles evaluated osteogenic potential and pharmacodynamic activity in postmenopausal osteoporosis models, highlighting nanotechnology-assisted therapeutic delivery systems.[8] Additionally, she contributed to research exploring TLR4/NF-κB and Keap1/Nrf2 signaling pathways in rheumatoid arthritis using perillyl alcohol interventions.[2]

Her review publications further discuss CRISPR/Cas9 technologies in neurological disorders, drug repurposing strategies for stroke intervention, and glial cell responses in neurodegenerative conditions.[5]

Publications

Selected Research Articles

  1. Gautam N, Sharma P, Chaudhary A, et al. Investigating the osteogenic potential of bone-targeted daidzein loaded hydroxyapatite nanoparticles for postmenopausal osteoporosis. Journal of Drug Targeting, 2025.
  2. Sarmah D, Sarkar A, Datta A, et al. Cardiolipin-mediated alleviation of mitochondrial dysfunction is a neuroprotective effect of statin in ischemic stroke. ACS Chemical Neuroscience, 2023.
  3. Puppala ER, Jain S, Saha P, et al. Perillyl alcohol attenuates rheumatoid arthritis via regulating TLR4/NF-κB and Keap1/Nrf2 signaling pathways. Phytomedicine, 2022.

Review Articles

  • Advancement in CRISPR/Cas9 technology to better understand and treat neurological disorders.
  • Drug repurposing for stroke intervention.
  • Glial cells response in stroke.

Research Impact

The research contributions of Antra Chaudhary demonstrate interdisciplinary relevance across pharmacology, neuroscience, and biomedical sciences. Her publications address clinically significant challenges associated with osteoporosis, ischemic stroke, inflammatory diseases, and oxidative stress-mediated tissue injury.[11]

Her collaborative work in molecular pharmacology and translational therapeutics contributes to ongoing scientific efforts aimed at developing safer and more effective treatment strategies. The integration of medicinal plant research, nanotechnology-based drug delivery systems, and cellular signaling investigations highlights the translational significance of her scientific profile.[2]

Award Suitability

Antra Chaudhary’s academic profile reflects sustained engagement in experimental pharmacology, translational biomedical research, and scientific dissemination through peer-reviewed publications and conference presentations. Her recognition through the Young Investigator Award at IPC-IPSCON 2025 further demonstrates professional acknowledgment of her contributions within the pharmacological research community.[3]

Her expertise in advanced laboratory techniques, coupled with her publication record and participation in international scientific activities, supports her suitability for academic recognition in the field of pharmacology and bone research. The interdisciplinary scope of her work aligns with contemporary priorities in therapeutic innovation and disease prevention.

Conclusion

Antra Chaudhary represents an emerging researcher in pharmacology whose scientific activities encompass bone pharmacology, oxidative stress biology, neuroprotection, and translational therapeutics. Through experimental research, scholarly publications, and active participation in scientific conferences, she has contributed to advancing knowledge in multiple biomedical domains. Her work continues to support the development of innovative therapeutic approaches aimed at improving disease management and bone health outcomes.[1]

References

  1. Jamia Hamdard University. (2026). Doctoral Research Profile of Antra Chaudhary.
  2. Jamia Hamdard University. (2026). Bone Pharmacology and Oxidative Stress Research Program.
  3. Elsevier. (2025). Pharmacological approaches in osteoporosis and translational therapeutics.
  4. Drug Discovery Today. (2022). Drug repurposing for stroke intervention.
    https://doi.org/10.1016/j.drudis.2022.03.014
  5. National Institute of Pharmaceutical Education and Research. (2020). MS Research Project Documentation.

Áron Mészáros | Health Professions | Research Excellence Award

Published on by World Science Awards

Mr. Áron Mészáros | Health Professions | Research Excellence Award

Hungarian University of Sport Science | Hungary

Mr. Áron Gergely Mészáros is a Hungarian strength and conditioning specialist and researcher with extensive experience in elite basketball performance and sports science. With a professional background as a former first-division basketball player, he has transitioned into high-level coaching and diagnostics, contributing to national teams and leading academies, including the Hungarian Basketball Federation and Vasas Basketball Academy. His expertise spans movement quality assessment, sport-specific performance testing, injury prevention, and load monitoring using advanced technologies such as VO₂ max analysis, lactate testing, and LPS systems. Mészáros has authored multiple peer-reviewed publications in international journals, focusing on youth athlete development and performance analytics. His work supports evidence-based training practices and contributes significantly to athlete health, performance optimization, and the advancement of sports science methodologies globally.

Citation Metrics (Scopus)

3
2
1
0

Citations
1

h-index
1

Documents
2

Citations

h-index

Documents

Featured Publications

Muhammad Ali Ibrahim Kazi | Medicine and Dentistry | Research Excellence Award

Published on by World Science Awards

Dr. Muhammad Ali Ibrahim Kazi | Medicine and Dentistry | Research Excellence Award

Anne Arundel Medical Center | United States

Dr. Muhammad Ali Ibrahim Kazi, MD, MBBS is a PGY-2 Internal Medicine resident at Anne Arundel Medical Center, Maryland, with strong academic training from Aga Khan University and international clinical experience. He has successfully completed all USMLE steps and is actively engaged in outcomes-based and real-world evidence research, particularly in gastroenterology, hepatology, inflammatory bowel disease, metabolic disorders, and GLP-1–based therapies. Dr. Kazi has multiple peer-reviewed publications, including PubMed-indexed articles and book chapters, and an extensive portfolio of ongoing multicenter cohort studies using large databases such as TriNetX. His work has been presented at major global forums including DDW, ACG, and AASLD. Beyond academia, he demonstrates strong societal impact through leadership in health education, cancer awareness, homelessness outreach, and global community service initiatives.

ORCID Profile

Featured Publications

Turkan Mutlu Yar | Medicine and Dentistry | Research Excellence Award

Published on by World Science Awards

Assist. Prof. Dr. Turkan Mutlu Yar | Medicine and Dentistry | Research Excellence Award

Ordu University Faculty of Medicine | Turkey

Dr. Turkan Mutlu Yar is a dedicated Doctor Ogretim Uyesi in the Department of Medical Parasitology at Ordu University, Faculty of Medicine, where she has been contributing to academic research, teaching, and diagnostics since 2023. She completed her PhD in Parasitology at İnönü University in 2015, with a thesis focused on the effectiveness of PCR in diagnosing Trichomonas infections in male patients. Her academic background also includes a thesis-based Master’s degree in Parasitology, a non-thesis Master’s degree in Biology Teaching, and a Bachelor’s degree in Biology from Fırat University. Dr. Yar’s research expertise spans intestinal parasites, cystic echinococcosis, trichomoniasis, zoonotic parasitic diseases, diagnostic molecular methods, and machine learning applications in parasitology. She has authored numerous peer-reviewed articles in international journals, including studies on Helicobacter pylori, Toxoplasma gondii, Toxocara species, and intestinal parasite prevalence in clinical and community settings. Her collaborative work also explores the antiparasitic effects of plant extracts, decision tree algorithms for disease severity, and risk factor modeling for parasitic infections. In addition, she has contributed multiple book chapters on parasitic diseases, zoonotic infections, liver trematodes, free-living amoebae, and hospital-acquired parasitic pathogens.

Citation Metrics (Scopus)

4
3
2
1
0

Citations
3

Documents
3

h-index
1

Citations

Documents

h-index

Featured Publications

 

Dujiang Yang | Health Professions | Best Researcher Award

Published on by World Science Awards

Dr. Dujiang Yang | Health Professions | Best Researcher Award

The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University Spinal Surgery Group | China

Dr. Dujiang Yang is currently pursuing his graduate studies in Traditional Chinese Medicine (Orthopedics and Traumatology) at Southwest Medical University (September 2023–June 2026). Despite being in training, he has already established an exceptionally prolific academic record, demonstrating strong research capability and outstanding scientific productivity. As the first author, he has published 43 English SCI-indexed papers, one Chinese Peking University Core article, several regular English journal papers, and additional Chinese publications. His cumulative SCI impact factor as first author has reached 264.5, reflecting both depth and influence in interdisciplinary biomedical research. His publications span top-tier journals including Annals of the Rheumatic Diseases (IF=20.6), Journal of Extracellular Vesicles (IF=14.5), Advanced Science (IF=14.3), Leukemia (IF=13.4), Cardiovascular Research (IF=13.2), Angiogenesis (IF=9.2), British Journal of Pharmacology (IF=7.7), and many others across fields such as immunology, degenerative diseases, oncology, tissue engineering, and stem cell therapies. His research interests are broad yet cohesive, focusing on molecular mechanisms of disease, regenerative medicine, biomaterials, single-cell analysis, and translational therapeutic strategies. In addition to research articles, he has also contributed multiple commentary papers in SCI journals, including a notable commentary in JAMA Network Open (IF=9.7). Beyond published work, Yang also has several manuscripts under review or accepted, including research utilizing multi-omics approaches, machine learning, network pharmacology, UHPLC-Q-Orbitrap-ESI-MS, and spatial transcriptomics, further demonstrating advanced methodological skills and translational vision. His work—ranging from tendon repair, osteoarthritis treatment, muscle regeneration, virology, to stem cell-based therapy—reflects a rare integration of modern biomedical science with traditional Chinese medicine perspectives. Yang has actively contributed to multiple funded scientific research projects under the supervision of Professor Guoyou Wang. His roles include project design, experimental execution, and manuscript preparation. Key projects include: a National Natural Science Foundation project exploring mechanisms of Shaoyang Shenggu prescription in regulating IL-17/NF-κB pathways to inhibit chondrocyte senescence; and several Sichuan Provincial research grants focused on network pharmacology, TGF-β/GPX4 signaling, iron-death mechanisms, and therapeutic evaluation of traditional herbal approaches in knee osteoarthritis.

Profile: ORCID

Featured Publications

  1. (2025). Navigating the complex landscape of DPP4 inhibition in inflammation: From novel mechanisms to unresolved translational challenges. Inflammation Research.

  2. (2025). USP5-laden ApoEVs and E2F1 stabilization in disc repair: Unresolved questions on senescence, specificity and endosomal escape. Journal of Extracellular Vesicles.

  3. (2025). Advancing the tendinopathy triad: Comment on “Tendinopathy: The interplay between mechanical stress, inflammation, and vascularity”. Advanced Science.

  4. (2025). Time to move beyond treatment initiation: Implementing risk-stratified therapy in fracture liaison services. Osteoporosis International.

 

Aurore Sajust de Bergues de Escalup | Medicine and Dentistry | Research Excellence Award

Published on by World Science Awards

Mrs. Aurore Sajust de Bergues de Escalup | Medicine and Dentistry | Research Excellence Award

Fondation Adolphe de Rothschild Hospital | France

Dr. Aurore Sajust de Bergues de Escalup is a radiology resident specializing in advanced neuroimaging, thoracic imaging, and musculoskeletal diagnostic modalities, with a growing research portfolio in artificial intelligence–enhanced medical imaging. She is currently completing the advanced phase of her radiology residency at the Hôpital Fondation Adolphe de Rothschild, focusing on neuroradiology and head-and-neck imaging, while simultaneously advancing her research interests in biomedical image analysis and quantitative MRI. Dr. Sajust de Bergues de Escalup holds a Master’s degree in Biomedical Engineering (BioImaging Specialization), awarded with honors, and completed at the PARCC laboratory (Inserm UMR 970). She was awarded the Année Recherche scholarship (ARS), supporting her contributions to translational imaging research. Her academic foundation includes competitive rankings in French national medical examinations (PACES rank: 52; ECN rank: 1227) and early international scientific exposure through her participation in the Biomed Research Academy at the University of Pennsylvania. Her recent peer-reviewed publications reflect an interdisciplinary approach combining clinical expertise and innovation. These include studies on synthetic MRI for optic nerve pathology, deep learning–based MRI reconstruction techniques, and CT phenotypes of interstitial lung disease in autoimmune disorders. Collectively, her work contributes to improving diagnostic accuracy, reducing scan times, and advancing precision imaging in ophthalmologic and thoracic conditions. Her collaborations span multiple major French academic hospitals, including Hôpital Robert-Debré, Hôpital Henri-Mondor, Hôpital Bichat, and the Hôpital de la Timone. Fluent in French and English, she has developed both clinical and research experience across pediatric radiology, emergency imaging, cardiothoracic radiology, and uro-gynecological imaging. Her long-term vision is to contribute to the integration of artificial intelligence and quantitative imaging biomarkers to enhance clinical decision-making and improve patient outcomes in neuroradiology and systemic disease evaluation.

Profile: ORCID

Featured Publications

Sajust de Bergues de Escalup, A., Lecler, A., Poirion, É., Papeix, C., Deschamps, R., Milea, D., Savatovsky, J., Duron, L., & O’Shaughnessy, E. (2025). Deep learning-based image reconstruction significantly improves image quality of MRI examinations of the orbit at 3 Tesla. Diagnostic and Interventional Imaging.

Sajust de Bergues de Escalup, A., Duron, L., Koskas, P., Poirion, É., Papeix, C., Deschamps, R., Milea, D., O’Shaughnessy, E., Savatovsky, J., Fournier, L., et al. (2025). Synthetic MRI for detecting abnormal signals in the optic nerves. Investigative Radiology